Tweet
As more and more 'normal' people are having their genomes sequenced and published, especially as part of the normal counterpart to a cancer genome, there is the question of what else you can do with this information. If it is published and downloadable, what obstacles are there to stop a public spirited researcher letting that data become part of the 1000 genomes project. It would squeeze extra use out of the data, and would improve the numbers of the 1000 genomes. Just wondering really.
-
The field of epigenetics has traditionally concentrated more on DNA and how changes like methylation and phosphorylation of histones impact gene expression and regulation. However, our increased understanding of RNA modifications and their importance in cellular processes has led to a rise in epitranscriptomics research. “Epitranscriptomics brings together the concepts of epigenetics and gene expression,” explained Adrien Leger, PhD, Principal Research Scientist on Modified Bases...Yesterday, 07:01 AM -
Proteins are often described as the workhorses of the cell, and identifying their sequences is key to understanding their role in biological processes and disease. Currently, the most common technique used to determine protein sequences is mass spectrometry. While still a valuable tool, mass spectrometry faces several limitations and requires a highly experienced scientist familiar with the equipment to operate it. Additionally, other proteomic methods, like affinity assays, are constrained...04-04-2024, 04:25 PM